CAS ID: | 3230-94-2 |
Molecular Formula: | C9H19N3O6 |
Molecular Weight: | 265.3 g/mol |
Monoisotopic Mass: | 265.127 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT01847651 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | May 7, 2013 | Last Verified | October 22, 2015 |
Sponsor | Imperial College London |
Trial Record 2
ClinicalTrial ID | NCT00305591 | Disease | Liver fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | March 22, 2006 | Last Verified | May 29, 2015 |
Sponsor | Imperial College London |
Trial Record 3
ClinicalTrial ID | NCT01722578 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | November 7, 2012 | Last Verified | February 8, 2017 |
Sponsor | Dayanand Medical College and Hospital |
Trial Record 4
ClinicalTrial ID | NCT01440829 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Completed |
First Received | September 27, 2011 | Last Verified | December 19, 2012 |
Sponsor | Fourth Military Medical University |
PubChem: | 10220941 |
ChEMBL: |